Petra Acquisition, Inc. Warrant
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch PAICW and buy or sell other stocks, ETFs, and their options commission-free!About PAICW
Revelation Biosciences, Inc. is a clinical-stage life sciences company, which focuses on the development of immunologic-based therapies for the prevention and treatment of disease. Its product candidates include REVTx-99b, its lead therapeutic candidate being developed for allergic rhinitis and chronic nasal congestion, REVDx 501, a rapid home use diagnostic that can be used to detect any respiratory viral infection, regardless of virus type or strain, without the need for specialized instrumentation, and REVTx 200, an intranasal immunomodulator adjunct to be used in combination with an intramuscular vaccination for more complete immunity.
CEOJames M. Rolke
CEOJames M. Rolke
Employees—
Employees—
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2019
Founded2019
Employees—
Employees—
PAICW Key Statistics
Market cap—
Market cap—
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume20.81K
Average volume20.81K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.0231
52 Week high$0.0231
52 Week low$0.004
52 Week low$0.004
Stock Snapshot
Petra Acquisition, Inc. Warrant(PAICW) stock is priced at $0.57.
On 2025-12-05, Petra Acquisition, Inc. Warrant(PAICW) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 20.81K.
Over the past 52 weeks, Petra Acquisition, Inc. Warrant(PAICW) stock has traded between a high of $0.02 and a low of $0.00.
Over the past 52 weeks, Petra Acquisition, Inc. Warrant(PAICW) stock has traded between a high of $0.02 and a low of $0.00.